Cleared Traditional

K180779 - Savina 300

K180779 is the FDA 510(k) clearance for Savina 300 by Dragerwerk AG & CO Kgaa. It is a Class 2 Anesthesiology device (product code CBK) cleared through the Traditional 510(k) pathway after a 297-day FDA review.

K180779 · Dragerwerk AG & CO Kgaa · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2019
Decision
297d
Days
Class 2
Risk

K180779 is an FDA 510(k) clearance for the Savina 300. Classified as Ventilator, Continuous, Facility Use (product code CBK), Class II - Special Controls.

Submitted by Dragerwerk AG & CO Kgaa (Lübeck, DE). The FDA issued a Cleared decision on January 17, 2019 after a review of 297 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5895 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dragerwerk AG & CO Kgaa devices

Submission Details

510(k) Number K180779 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 2018
Decision Date January 17, 2019
Days to Decision 297 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
157d slower than avg
Panel avg: 140d · This submission: 297d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CBK Ventilator, Continuous, Facility Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5895
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBK Ventilator, Continuous, Facility Use

All 190
Devices cleared under the same product code (CBK) and FDA review panel - the closest regulatory comparables to K180779.
Trilogy Evo
K181166 · Respironics, Inc. · Jul 2019
Trilogy Evo Universal
K181170 · Respironics, Inc. · Jul 2019
SERVO-U Ventilator System version 2.1
K180098 · Maquet Critical Care AB · Mar 2019
Nihon Kohden NKV-550 Series Ventilator System
K181695 · Nihon Kohden Orangemed, Inc. · Dec 2018
TV-100
K173973 · Bio-Med Devices, Inc. · Jul 2018
Astral 100/150
K172875 · Resmed, Ltd. · Apr 2018